TA187: Crohn's disease - infliximab (review) and adalimumab (review of TA40)
This is a discussion on TA187: Crohn's disease - infliximab (review) and adalimumab (review of TA40) within the Updates from the Technology Assessment Authorities forum, part of the Industry News and Updates category; The summary for the published technology appraisal on Crohn's disease - infliximab (review) and adalimumab (review of TA40). It links ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
05-19-2010, 06:56 AM
|
|||
|
|||
TA187: Crohn's disease - infliximab (review) and adalimumab (review of TA40)
The summary for the published technology appraisal on Crohn's disease - infliximab (review) and adalimumab (review of TA40). It links to the published guidance and key documents.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| TA40: Crohn's disease - infliximab | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| TA111: Alzheimer's disease - donepezil, galantamine, rivastigmine (review) and memantine | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| Adalimumab Reduces Hospitalization, Major Surgery for Crohn's Disease | industry_news | Other Clinical Pharmacy News | 0 | 10-09-2008 07:41 PM |
| Adalimumab and Etanercept Edge Infliximab in RA Therapy | industry_news | Other Clinical Pharmacy News | 0 | 09-18-2008 01:17 PM |
| Maintenance With Infliximab Effective in Crohn's Disease | industry_news | Other Clinical Pharmacy News | 0 | 07-21-2008 10:51 AM |
© 2008 DrugManagementForum™ powered by |
 |